Communication from the AGSM of Brighter AB (publ).

Report this content

Brighter’s Annual General Shareholders Meeting was held on Wednesday May 16, 2018 at the company’s address in Stockholm, Kista.

The annual general meeting voted unanimously in accordance with proposals from the official notification of the annual general meeting, except for the change of bylaws in bullet point 15 from the notification. Due to erroneous wording in bullet point 15 in the official notification of the annual general meeting it was decided to remove that decision from the agenda.

For more information, please contact:

Truls Sjöstedt, CEO 
Telefon: +46 709 73 46 00      

E-post:  truls.sjostedt@brighter.se

Henrik Norström, COO   
Telefon: +46 733 40 30 45      
E-post: henrik.norstrom@brighter.se

About Brighter
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se

About Actiste
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Actiste is connected via an autonomous and secure mobile connection, and information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed with patient consent.

Validated user-generated data, such as glucose levels or insulin doses, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. www.actiste.com

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 – 454 32 50, CorporateFinance@remium.comwww.remium.com.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 16:20 CEST on May 16, 2018.

Documents & Links